MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
about
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinomaThe novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology EuroMiR-26a functions as a tumor suppressor in ambient particulate matter-bound metal-triggered lung cancer cell metastasis by targeting LIN28B-IL6-STAT3 axis.The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease.TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
P2860
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@ast
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@en
type
label
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@ast
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@en
prefLabel
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@ast
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@en
P2093
P2860
P50
P1433
P1476
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
@en
P2093
Anneleen Beckers
Belamy B Cheung
Daniel R Carter
Frank Westermann
Gert Van Peer
Glenn M Marshall
Jan J Molenaar
Jason M Shohet
Johannes H Schulte
Kristina Althoff
P2860
P304
P356
10.1016/J.CANLET.2015.06.015
P407
P577
2015-06-26T00:00:00Z